which of the following antiarrhythmic drug is avoided in a patient with interstitial lung disease ?
**Core Concept**
The question is testing the interaction between antiarrhythmic medications and interstitial lung disease (ILD). ILD is a condition characterized by inflammation and scarring in the lung tissue, which can impair gas exchange and oxygenation. Certain medications can exacerbate ILD by inducing pulmonary toxicity.
**Why the Correct Answer is Right**
Sotalol is an antiarrhythmic drug that belongs to the class III category. It works by blocking potassium channels, which prolongs the action potential duration and refractory period in the heart. However, sotalol can also cause pulmonary fibrosis, a condition that is similar to ILD. In patients with pre-existing ILD, the risk of pulmonary toxicity from sotalol is significantly increased, making it a contraindication in this population.
**Why Each Wrong Option is Incorrect**
**Option A:** Amiodarone is another antiarrhythmic drug that can cause pulmonary toxicity, but it is not as strongly associated with ILD as sotalol. Amiodarone is often used in patients with heart failure and can be beneficial in certain cases, but it requires careful monitoring.
* **Option B:** Quinidine is a class IA antiarrhythmic drug that is not commonly used today due to its side effect profile. It is not specifically contraindicated in ILD patients.
* **Option D:** Flecainide is a class IC antiarrhythmic drug that is generally well-tolerated and not associated with pulmonary toxicity. It is often used in patients with atrial fibrillation and flutter.
**Clinical Pearl / High-Yield Fact**
When prescribing antiarrhythmic medications, it is essential to consider the patient's underlying medical conditions, including ILD. The risk of pulmonary toxicity from certain medications can be life-threatening, and careful monitoring is crucial to prevent adverse outcomes.
**Correct Answer:** C. Sotalol is avoided in a patient with interstitial lung disease due to its potential to cause pulmonary fibrosis and exacerbate ILD.